Correlation Between Nuvectis Pharma and Agenus
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Agenus Inc, you can compare the effects of market volatilities on Nuvectis Pharma and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Agenus.
Diversification Opportunities for Nuvectis Pharma and Agenus
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Nuvectis and Agenus is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Agenus go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Agenus
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 0.8 times more return on investment than Agenus. However, Nuvectis Pharma is 1.25 times less risky than Agenus. It trades about 0.0 of its potential returns per unit of risk. Agenus Inc is currently generating about -0.03 per unit of risk. If you would invest 844.00 in Nuvectis Pharma on September 2, 2024 and sell it today you would lose (340.00) from holding Nuvectis Pharma or give up 40.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Agenus Inc
Performance |
| Timeline |
| Nuvectis Pharma |
| Agenus Inc |
Nuvectis Pharma and Agenus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Agenus
The main advantage of trading using opposite Nuvectis Pharma and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Agenus vs. Tff Pharmaceuticals | Agenus vs. Eliem Therapeutics | Agenus vs. Inhibrx | Agenus vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |